In the NAFLD group, LFABP levels showed a moderate positive correlation with the NAS score (r = 0.58, P < .001), ballooning degeneration (r = 0.67, P < .001), and lobular inflammation (r = 0.62, P < .001) (Table 2), a weak positive correlation with fibrosis, and no correlation with steatosis. This evidence concerns the gene FABP1 and metabolic dysfunction-associated steatotic liver disease.